(Q35556914)

8 August 2017

1 reference

title

Cytokines in inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

8 August 2017

main subject

0 references

2

O. H. Nielsen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1455185

28 September 2022

author name string

Ahnfelt-Rønne I

3

1 reference

8 August 2017

J. Brynskov

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1455185

28 September 2022

I. Ahnfelt-Rønne

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1455185

28 September 2022

K. Bendtzen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1455185

28 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1455185

28 September 2022

publication date

1 November 1992

1 reference

Scandinavian Journal of Gastroenterology

8 August 2017

published in

1 reference

8 August 2017

volume

27

1 reference

8 August 2017

issue

11

1 reference

8 August 2017

page(s)

897-906

1 reference

A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Final report on a placebo-controlled, double-blind, randomized, multicentre trial of cyclosporin treatment in active chronic Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Immune hormones (cytokines); pathogenic role in autoimmune rheumatic and endocrine diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Native interleukin 1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Autoantibodies to cytokines--friends or foes?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Increased plasma interleukin-1 activity in women after ovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Identification of a specific interleukin 1 inhibitor in the urine of febrile patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Interleukin 1 receptor antagonist. A new member of the interleukin 1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

The interleukin-2 T-cell system: a new cell growth model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Interleukin 2 high-affinity receptor expression requires two distinct binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Soluble interleukin 2 receptors in autoimmune chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Soluble interleukin-2 receptors in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Expression of interleukin 2 receptors on activated human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Significant increase of interleukin 6 production in blood mononuclear leukocytes obtained from patients with active inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Properties of the novel proinflammatory supergene "intercrine" cytokine family.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Molecular mapping of the human major histocompatibility complex by pulsed-field gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

MHC class II-associated variation in the production of tumor necrosis factor in mice and humans: relevance to the pathogenesis of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Lymphokines and the intestinal immune response. Role in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Salicylazosulfapyridine (Salazopyrin) effect on endotoxin-induced production of interleukin-1-like factor from human monocytes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Sulfasalazine inhibits the binding of TNF alpha to its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Interaction of glucocorticoids with macrophages. Identification of glucocorticoid receptors in monocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Mechanism of action of glucocorticosteroids. Inhibition of T cell proliferation and interleukin 2 production by hydrocortisone is reversed by leukotriene B4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Human macrophage activation. Modulation of mannosyl, fucosyl receptor activity in vitro by lymphokines, gamma and alpha interferons, and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Induction of Interleukin 2 Messenger RNA Inhibited by Cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Cyclosporin A inhibits the production of gamma interferon (IFN gamma), but does not inhibit production of virus-induced IFN alpha/beta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Activation of lamina propria T cells induces crypt epithelial proliferation and goblet cell depletion in cultured human fetal colon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

The cyclo-oxygenase inhibitor, piroxicam, enhances cytokine-induced lymphocyte proliferation in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Prostaglandin E inhibits the production of human interleukin 2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Interleukin-1-induced anorexia in the rat. Influence of prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Inhibition of Leukotriene Biosynthesis and Polymorphonuclear Leukocyte Functions by Orally Active Quinolylmethoxyphenylamines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Pharmacology of the pyrroloimidazole, SK&F 105809--I. Inhibition of inflammatory cytokine production and of 5-lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

In vitro study of mediators of inflammation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Cytokine gene regulation by PGE(2), LTB(4) and PAF

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Oxygen radicals, inflammation, and tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

Cachectin: more than a tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000160

10.3109/00365529209000160

21 January 2018

Identifiers

DOI

1 reference

8 August 2017

1 reference